TGFB1 and breast carcinoma: Instead of targeting TGF‐β signalling components, inhibition of the EV trafficking within the TME was conceived to disable the communication between CAFs and breast cancer cells, blocking CAF‐sEVs as source of TGF‐β, and preventing breast cancer metastasis.